Cargando…
A Somatic Activating NRAS Variant Associated with Kaposiform Lymphangiomatosis
PURPOSE: Kaposiform lymphangiomatosis (KLA) is a rare, frequently aggressive, systemic disorder of the lymphatic vasculature, occurring primarily in children. Even with multimodal treatments, KLA has a poor prognosis and high mortality rate secondary to coagulopathy, effusions and systemic involveme...
Autores principales: | Barclay, Sarah F., Inman, Kyle W., Luks, Valerie L., McIntyre, John B., Al-Ibraheemi, Alyaa, Church, Alanna J., Perez-Atayde, Antonio R., Mangray, Shamlal, Jeng, Michael, Kreimer, Sara R., Walker, Lori, Fishman, Steven J., Alomari, Ahmad I., Chaudry, Gulraiz, Trenor, Cameron C., Adams, Denise, Kozakewich, Harry P.W., Kurek, Kyle C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565516/ https://www.ncbi.nlm.nih.gov/pubmed/30542204 http://dx.doi.org/10.1038/s41436-018-0390-0 |
Ejemplares similares
-
Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition
por: Chowers, Guy, et al.
Publicado: (2022) -
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences
por: Ji, Yi, et al.
Publicado: (2019) -
Sirolimus in the treatment of kaposiform lymphangiomatosis
por: Zhou, Jiangyuan, et al.
Publicado: (2021) -
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis
por: Ozeki, Michio, et al.
Publicado: (2019) -
Refractory kaposiform lymphangiomatosis relieved by splenectomy
por: Lan, Yuru, et al.
Publicado: (2023)